147.91
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DVA Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$148.13
Aprire:
$147.49
Volume 24 ore:
620.83K
Relative Volume:
0.59
Capitalizzazione di mercato:
$9.89B
Reddito:
$13.64B
Utile/perdita netta:
$1.05B
Rapporto P/E:
15.48
EPS:
9.555
Flusso di cassa netto:
$1.31B
1 W Prestazione:
-1.43%
1M Prestazione:
-1.38%
6M Prestazione:
+17.50%
1 anno Prestazione:
+5.63%
Davita Inc Stock (DVA) Company Profile
Nome
Davita Inc
Settore
Industria
Telefono
310-536-2668
Indirizzo
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, ENSG, UHS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
DVA
Davita Inc
|
147.91 | 9.89B | 13.64B | 1.05B | 1.31B | 9.555 |
|
HCA
Hca Healthcare Inc
|
488.00 | 109.10B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
196.64 | 17.23B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.41 | 12.79B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
200.11 | 11.69B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
182.41 | 11.13B | 17.36B | 1.51B | 849.25M | 23.15 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2023-08-07 | Aggiornamento | UBS | Neutral → Buy |
| 2022-11-01 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Downgrade | UBS | Buy → Neutral |
| 2022-08-19 | Ripresa | UBS | Buy |
| 2022-06-21 | Reiterato | BofA Securities | Underperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-12 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-01-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Aggiornamento | UBS | Sell → Neutral |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2018-12-14 | Iniziato | Barclays | Overweight |
| 2018-11-28 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Iniziato | UBS | Sell |
| 2018-11-08 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2017-12-07 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Downgrade | Jefferies | Buy → Hold |
| 2016-12-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Davita Inc Borsa (DVA) Ultime notizie
DaVita Inc stock (US23804L1035): Why Google Discover changes matter more now - AD HOC NEWS
Here's why you should retain DaVita stock in your portfolio for now - MSN
KBC Group NV Raises Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Inc (DVA) Shares Fall 3.3% -- What GF Score of 92 Tells I - GuruFocus
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): Is kidney care demand strong enough to drive steady investor retur - AD HOC NEWS
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Inc. stock rises Monday, still underperforms market - MarketWatch
DaVita Inc stock (US23804L1035): Why its kidney care dominance matters more now for investors - AD HOC NEWS
DaVita Inc. (DVA) Is Down 9% This Year. Here Is Why - MSN
Will DaVita’s (DVA) Push Into Patient-Centric Data Access Reshape Its Digital Health Narrative? - Sahm
Assessing DaVita (DVA) Valuation After Earnings Beat Buyback Debate And EPS Guidance Questions - Yahoo Finance
DaVitaFurther Upside Is Trickier (Rating Downgrade) (NYSE:DVA) - Seeking Alpha
Aberdeen Group plc Has $230,000 Stake in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock (US23918K1088): Is its dialysis dominance strong enough to unlock new upside? - AD HOC NEWS
DaVita HealthCare (DVA) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Reasons to Keep DaVita Stock in Your Investment Portfolio at This Time - Bitget
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Yahoo Finance
Zacks Downgrades DaVita Stock Rating - National Today
DaVita Inc stock: What investors need to know about its dialysis dominance now - AD HOC NEWS
California law limiting dialysis providers' profits voided by US appeals court - Reuters
DaVita, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Day in the Life: Ansel, DaVita Home Hemodialysis Registered Nurse - CSRwire
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health - csrwire.com
Day in the Life: Jena, DaVita Social Worker - CSRwire
Day in the Life: Cristina, DaVita PD Registered Nurse - CSRwire
DVA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
DaVita Inc. stock underperforms Thursday when compared to competitors - MSN
DaVita Inc. (DVA) Stock Price, News, Quote & History - Yahoo! Finance Canada
DaVita Inc. (DVA.MX) Stock Price, News, Quote & History - Yahoo! Finance Canada
DaVita Entities’ Drug Purchases Exempt From Louisiana Sales Tax - news.bloombergtax.com
DaVita Inc. stock: Steady earnings beat amid market dips—what's next? - AD HOC NEWS
DaVita Arms Freed From Local La. Tax On Medicare Drugs - Law360
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know - Yahoo Finance
DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
DaVita Inc Stock: Leading Dialysis Provider Faces Evolving Healthcare Landscape in 2026 - AD HOC NEWS
DaVita: A Digital Guardian: AI-Powered Insights Bring Patients and Clinicians Closer - FinanzNachrichten.de
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock - Yahoo Finance
Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market - Yahoo Finance
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
Heart Risks Go Beyond the Heart: Don’t Forget to Check Blood Sugar and Kidney Health - GlobeNewswire Inc.
Assenagon Asset Management Trims DaVita Stake - National Today
Assenagon Asset Management S.A. Trims Holdings in DaVita Inc. $DVA - MarketBeat
DaVita stock dips 1.49% as company promotes home dialysis benefits - Traders Union
Wedge Capital Management L L P NC Purchases 45,998 Shares of DaVita Inc. $DVA - MarketBeat
Davita Inc Azioni (DVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):